InvestorsHub Logo
Followers 16
Posts 1362
Boards Moderated 0
Alias Born 02/06/2014

Re: BioBS2012 post# 220996

Friday, 05/29/2015 5:55:36 PM

Friday, May 29, 2015 5:55:36 PM

Post# of 346183
Bio,

I am looking at all of these expression levels and trying to extrapolate how bavi factors in comparison. I know Bavi has a much broader efficacy and response with patients. Assuming great results from Sunrise, could you provide some comparative details. If you wish. Thanks.

Efficacy Summary: Median Overall Survival by PD-L1 Expression



Opdivo Docetaxel

=1% PD-L1 expression level

HR = 0.59 (95% CI, 0.43- 0.82)
17.2 months 9.0 months


<1% PD-L1 expression level

HR = 0.90 (95% CI, 0.66- 1.24)
10.4 months 10.1 months


=5% PD-L1 expression level

HR = 0.43 (95% CI, 0.30-0.63)
18.2 months 8.1 months


<5% PD-L1 expression level

HR = 1.01 (95% CI, 0.77- 1.34)
9.7 months 10.1 months


=10% PD-L1 expression level

HR = 0.40 (95% CI, 0.26-0.59)
19.4 months 8.0 months


<10% PD-L1 expression level

HR = 1.00 (95% CI, 0.76- 1.31)
9.9 months 10.3 months
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News